MARKET

ADCT

ADCT

Adc Therapeutics Sa
NYSE
3.290
-0.250
-7.06%
After Hours: 3.390 +0.1 +3.04% 19:06 12/05 EST
OPEN
3.520
PREV CLOSE
3.540
HIGH
3.600
LOW
3.250
VOLUME
1.84M
TURNOVER
--
52 WEEK HIGH
4.800
52 WEEK LOW
1.050
MARKET CAP
407.56M
P/E (TTM)
-2.1742
1D
5D
1M
3M
1Y
5Y
1D
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
TipRanks · 15h ago
Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
RBC Capital Sticks to Its Buy Rating for ADC Therapeutics (ADCT)
TipRanks · 2d ago
Why Is ADC Therapeutics Plunging Today
Benzinga · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 2d ago
Promising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
TipRanks · 2d ago
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
TipRanks · 3d ago
More
About ADCT
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Webull offers ADC Therapeutics SA stock information, including NYSE: ADCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADCT stock methods without spending real money on the virtual paper trading platform.